← Back to patent-cliff list
CAS 832-53-1
2,3,4,5,6-Pentafluorobenzenesulfonyl chloride
Codes：Umirolimus-002
Application context (from source-drug indications)
冠状动脉再狭窄Umirolimus冠状动脉病变Umirolimus冠状动脉疾病Umirolimus不稳定型心绞痛Umirolimus缺血Umirolimus缺血性心脏病Umirolimus
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| UmirolimusUmirolimus | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-Ethoxyethanol→2,3,4,5,6-Pentafluorobenzenesulfonyl chloride→Pentafluorobenzenesulfonic acid 2-ethoxyethyl ester→(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-3-[1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2(R)-yl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-3,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-1H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.